Delivery Order SPE2DB24D2013-SPE2DB25FCJUT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,443.28 on July 28, 2025, for the supply of Briviact 100 mg tablets in a 60-count package. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to compete in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $1,057.82. This firm fixed-price delivery order, which is not set-aside, represents a competitive award to support federal medical procurement needs. The contract is set to complete by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 100 mg tablets in quantities of 60 units, with a ceiling value of $4,082.11. This contract represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The Defense Logistics Agency awarded a delivery order valued at $5,569.98 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 100mg tablets (60-count packages) at a ceiling value of $3,282.79. This delivery order represents a firm fixed-price contract with no set-aside designation, executed through open competition. The order is scheduled for ultimate completion by August 27, 2025, with performance occurring at AmerisourceBergen's corporate office location in...
- On July 30, 2025, the Defense Logistics Agency awarded a delivery order valued at $2,801.62 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract with DLA Troop Support Medical. The order is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.01 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count packaging) with a completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $1,905.41 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 25 mg on July 21, 2025, with a completion date of July 22, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $4,653.35 to AmerisourceBergen Drug Corp for Briviact 25 mg tablets (60-count units) on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJUTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Briviact 75 mg tablets (60-count units) with a ceiling value of $3,651.35. This firm fixed-price delivery order, which is expected to be completed by August 5, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's role as a prime vendor under this comprehensive global pharmaceutical support vehicle enables flexible fulfillment of diverse federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/4/25 |